-
Symbol
-
ACRS on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value
-
Latest Disclosed Shares Owned
-
11,281,950 shares
-
Security Ownership %
-
9.4%
Biosion, Inc. ownership in Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)
09 Jan 2026 - Biosion, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,281,950 shares of Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS).
This represents 9.4% ownership of the company.
This is the first filing by Bonita Biotech (HK) Ltd disclosing ownership of Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS).